
Trials for Type 1 Diabetes Cure 66
An anonymous reader writes "According to this New York Times article, the pharmaceutical companies and NIH are shunning research for a cure for Type 1 diabetes. There's no money in a cure using medicine with an expired patent. Dr Faustman (researcher/professor at Harvard Medical School) has cured type 1 diabetes in mice and has been approved for Phase 1 clinical trials in humans. The only problem is raising the money, which Lee Iacocca is helping with."
Non-NYT article link (Score:5, Informative)
No problem, I found a copy of the NYT article [joinleenow.org] on Lee Iacocca's page. (Hopefully the server holds up.) Enjoy.
The article is mixed up. (Score:4, Insightful)
The 'big bad pharmaceutical co' angle is mixed up too. This is a surgical procedure. There is no new pharmaceutical at the centre of it. But if new combinations of immunosuppressants prove specially well adapted to patients who have this procedure, that would quite likely be a new combination of features, and patent protection would likely be available for whatever it turns out to be, anyway.
-wb-
RTFA (Score:4, Informative)
They found that the treatment/drugs supposed to prepare the mice for transplant actually _cured_ the mice. The treatment was supposed to stop the immune system from blowing away the transplanted islet cells. But after the treatment the islet cells _regrew_ back. So there was no need for a transplant.
""No one had cured them," he said. "Here was this treatment that we thought would get them ready for a transplant but - eureka! - the diabetes was cured.""
Re:RTFA (Score:5, Informative)
I suggest reading the literature on the subject as well. It is well known that immune destruction starts off IDDM, but there is no evidence -- including regard to what is reported in the article -- that immune suppression revives beta-cells in patients who have none left. I.e. the large majority of humans with IDDM have long since lost all their beta cells to the destructive process that has run its course, and there is no bringing those cells back from the dead.
And I stick to what I said about the big bad pharma angle being mixed up too. If a drug or combination of drugs has a surprising new effect then patent protection is likely to be available on the usual conditions no matter how much noise to the contrary is made on
-wb-
Re:RTFA (Score:1, Informative)
RTRA (read the real article) (Score:2, Informative)
Re:Non-NYT article link (Score:2)
On the other hand, this is the first time I've ever clicked a link from Google News [google.ca], and ended up back at Slashdot.
Re:Non-NYT article link (Score:1)
We see true motivation of the big "IP" players (Score:2, Flamebait)
I think that's all you really need to know about the current state of play WRT patents and the like. Now how does a little inventor set about getting the protection that patents should have offered him, but don't?
Re:We see true motivation of the big "IP" players (Score:5, Insightful)
When it becomes uneconomical to develop a promising drug, usually because it treats too rare of a disease, but sometimes due to other reasons, we call those orphan drugs. Sometimes the government intervenes [fda.gov] and finishes the research. Maybe it'll happen this time.
Re:We see true motivation of the big "IP" players (Score:2, Flamebait)
Re:We see true motivation of the big "IP" players (Score:3, Insightful)
There is a reason
Re:We see true motivation of the big "IP" players (Score:5, Insightful)
Re:We see true motivation of the big "IP" players (Score:3, Interesting)
penniless orphans (Score:2)
Re:We see true motivation of the big "IP" players (Score:2)
And yes, there should be government regulations regarding h
The news I have been waiting for! (Score:5, Funny)
Re:The news I have been waiting for! (Score:2)
Re:The news I have been waiting for! (Score:2)
I'm sensitive to the issues/sufferers of diabetes: a family member and some friends have it. I was making a sarcastic remark, among other reasons, that animals such as mice are "cured" of disease even though we introduce it in their speicies (genetic manipulation, diet change) and we value these cures for humans even though we may chose to euthanise our pets.
As a Type 1 Diabetic (Score:5, Interesting)
Type 1 diabetics are in the minority, but we're still pretty big cash cows for certain companies. Besides the various types of insulin we need to survive, most diabetics that wish to succesfully manage the disease use additional products like disposeable needles, blood glucose meters and strips (big money), insulin pumps, and more. Potentially, it's many thousands of dollars per person per year and not many companies would want to lose that cashflow.
Re:As a Type 1 Diabetic (Score:2)
I had a dog who suffered diabetis for 5 years before he died. 2 shots a day. 1 in the morning and 1 at night.
In total, I purchased about 3500 needls, and 60 vials of insulin.
Trust me, I was being milked for medical supplies, out of insurance too =(.
Grump
Re:As a Type 1 Diabetic (Score:3, Insightful)
In this case, it won't be the big medical companies pushing it. It'll be insurers, which stand to save tons of money if they can cure diabetics. This overlaps with governments, since most western governments are paying at least some of the medical costs (medicare in the US, much larger programs in Canada and the EU).
And while the big medical corps may resist losing their cash cow, the companies that make generic drugs will gladly pump out the patent-expired medicines used by
Re:As a Type 1 Diabetic (Score:2)
So long as all the big insurers statistically get the same number of type-1 diabetics on their books, they can just past the cost througth to the premiums, and there is no great business advantage to a cure, because they would all end up cutting premiums or adding services until it all leveled out again.
There would be extra income available because cheaper insurance might allow more people to be insured, however they may wel
Re:As a Type 1 Diabetic (Score:1)
The big problem here is that any cure that is discovered will have to fight through several different interested groups with deep pockets. Insurance will have an angle, pharm's will have an angle, edcuation will have an angle, and probably some others I've forgotten. Most notably absent here is the public, the only benefactor of a cure. The hope is that common sense and a sense of public good would prevail somewhere causing the new cure to be doled out, but I have my concerns.
Irregardless of the potential
Re:As a Type 1 Diabetic (Score:2)
Re:As a Type 1 Diabetic (Score:2)
Re:As a Type 1 Diabetic (Score:2)
*Disclaimer* I am not a doctor, but these observations are based on my personal experience and the experiences of others I know and/or have read about. All changes in your treatment program should be made with the consulation of a medical professional. You may look for one that works with you the way you want.
Type II diabetes is a different disease (cause) in most cases. Insulin resistance from the body is normally what Type II is caused by. Solutions for that are exercise, diet, exercise and oh yeah,
public health care (Score:3, Interesting)
Re:public health care (Score:2)
It would mean going back to square one.
Re:public health care (Score:5, Informative)
Money for pure research projects up here is few and far between (although I'm not saying it's non-existent -- research at hospitals like Sick Kids in Toronto is excellent).
But, agreed...it'd sure be nice if someone took up the gauntlet and pursued a cure for Type 1 diabetes.
-psy
Re:public health care (Score:2)
Much to early for any conclusion (Score:5, Informative)
Re:Much to early for any conclusion (Score:2, Interesting)
Why expect pharmaceutical companies to pay? (Score:3, Interesting)
The medical community isn't working in our best interest alone. Scientists work in areas where the best interest of the individual overlaps with the best interest of their employer. There are times when the best interest of the individual does not match up with the best interest of any company and these areas of medicine are horribly neglected (see blueberries vs Lipitor, oxygen therapy vs blood pressure medication, low carb vs the AHA Diet, First Do No Harm [imdb.com]). I'm not saying that the doctors are wrong on all these things, I'm saying nobody is putting in the work to check up on them because there's nobody to pay for it.
If the only medical research that gets done is privately funded then the only medical advancements that get made will increase the income of medical companies. If that's the case, the cost of medical care can only go up (unless someone is taking someone else's business but that rarely happens)
I don't think this study is alone. Someone needs to fund this stuff or we'll all be taking out second mortgages because the medical community has convinced us we have to or we'll die.
Re:Why expect pharmaceutical companies to pay? (Score:4, Interesting)
And that is the research that the NIH is paying for.
Historically, the pharmaceuticals though get all of the attention because you don't hear about these drugs until they've decided to market them. It's really a shame.
Re:Why expect pharmaceutical companies to pay? (Score:2)
Any time you get an organization like that which works closely with the industry, there will be teams of people spinning and lobbying politicians to influence where funding goes and inevitably a system is setup where if you want to keep your job, you spend money where the industry wants you to.
I doubt the NIH has avoided the industry lapdogization common to government agencies in that kind of position.
NIH appears to be funding the research.... (Score:2)
stem cells (Score:3, Insightful)
Why? This statement is 100% false. For many diseases and disorders there is more than one method of treatment. For cancer, there is chemotherapy and radioation. Both work. Same thing for diabetes, if one method works, why not another?
Stem cell research can result in a cure for diabetes. The same thing can be true for Dr. Denise Faustman's treatment.
I'd have to say NYT either is biased against stem cell research or they just repeat another's bias.
Re:stem cells (Score:2)
Please, RTFA or the story title. The cure is for Type I diabetes. I don't know if it does anything for Type II, but maybe it is related to the spleen. Since the pancreas is the only vital organ than can grow back, the connection between the spleen and the pancreas in diabetes can b
Atkins for diabetics? (Score:1)
What happens when a person with type 2 DM goes on a low-carbohydrate, low-calorie diet [amazon.com] to help reduce the secretion of excess insulin into the bloodstream?
Re: (Score:2)
There is more than one source of stem cells (Score:1)
But stem cell research is *much* more important than just for diabetes.
So why do the bleeding-purple-heart liberals focus only on research with new lines of embryonic stem cells? What about umbilical stem cells or bone marrow stem cells?
Re:There is more than one source of stem cells (Score:2)
At least, that's my understanding of how stem cells work. I'm only a rocket scientist.
No money? (Score:2, Insightful)
Chemist/Pharmacist: Look! We found the cure for cancer, AIDS, and all forms of nerve injury!
Manager: Who cares? The patent's expired.... just throw it away...
Legal Pushers and Public Addicts (Score:3, Insightful)
I would like to suggest that this opinion of drug companies is, in some ways too generous; Its not their fault, its the economics and laws which we set up to drive pharmaceutical research and profits.
Similar outcomes different goals?: Illegal Drug dealers induce a dependency by pushing a prohibited substance, targeting any easy mark. Drug companies discover dependecies by hiring "researchers" to find substances which alleviate or "manage" pre-existing common diseases, targeting any sick person.
These "no-cure" drugs temporarily alleviate the symptoms of the diseases, and even extend the patients life (and thus profits), while, "unfortunately", rarely managing to fundamentally cure anything. When was a drug as useful as penicillin last discovered?
The really clever people are in marketing, its carefully created to spin the appearance of dedicated people attempting to find cures. I find that laughably naive, clearly the economic pressure precludes that from happening. However, I suspect many of the scientists and 'caring professionals' in the field prefer to believe that comfortable fallacy and self image.
To me this focus on researching pushable drugs, versus practical cures, is a natural outcome of allowing the humanitarian medical sciences to be solely driven by raw capitalism and simple greed.
The pharmaceutical companies, will grow wealthier, and the poignant marketing campaigns, and "real soon now cures", will be glossy, slick and convincing, for as long as the hypocrisy continues.
Note: Where there are funds for any cure oriented research, it will typically be in areas where there is a huge PR payback in company image and good will factors.
We, the public, are the addicts, we pay the taxes, fund the basic research, and then have to drink their coolaid and swallow the bitter and expensive pills, just so we can feel better... for a while.
IMHO, there is no cure for this chronic disease of legalized "no-cure" drug pushing, except by radical surgery on the NIH and our health research laws.
Fund the competition (Score:2)
No big deal (Score:2)
Re:No big deal (Score:1)
The Razor and blades mentality to health care issues is killing people.
What's wrong w/ successful Edmonton Protocol?!? (Score:2)
Years ago, CBC's "Quirks & Quarks" science program
had at least 2 items (the later on a follow-up) on
transplating Islets from healthy donors into Type 1 diabetes sufferers.
[ Research was from University of Alberta ]
Trials have been going for years already, with
over 90% success rates. Not good enough?!?
What's the latest on this treatment...?
Re:What's wrong w/ successful Edmonton Protocol?!? (Score:2)
Re:What's wrong w/ successful Edmonton Protocol?!? (Score:1)
Generalizations and Big Picture Issues (Score:1)
Donations (Score:1)